Skip to main content

Preeclampsia has no cure. Doctors cannot predict who will develop it. It still kills tens of thousands of women every year. It remains one of the most under-researched conditions in pregnancy care. No new type of therapy exists that treats its underlying cause.

That research gap is part of a wider pattern. A 2021 McKinsey analysis found a stark funding split. Just 1% of health research and innovation spending goes to conditions that affect only women, once you set cancer aside. Preeclampsia is in that neglected group. So are gestational diabetes, heavy menstrual bleeding, endometriosis, and menopause. Together, those conditions affect hundreds of millions of women worldwide. Treatments are limited. Wrong diagnoses are common. In some cases the cause is still unknown.

The long-term cost of that neglect can be measured. A McKinsey analysis has found that women spend about 25% more of their lives in poor health than men. Longer lives have not always meant healthier lives. A major reason is that the conditions that make women sick have been underfunded and understudied. A large funding pledge announced in August 2025 is meant to start changing that.

What did the Gates Foundation pledge?

The Gates Foundation announced plans to invest $2.5 billion to advance women’s health. The focus is maternal, menstrual, gynecological, and sexual health. Foundation leaders have called it the largest investment the foundation has made in women’s health research and development. The commitment runs through 2030. It is designed to speed research in five areas that have long received little private or public funding. The need is especially great for women in low- and middle-income countries.

The plan has five priority areas. They are pregnancy care and vaccines for mothers, maternal health and nutrition, gynecological and menstrual health, new birth control options, and infections passed through sex. The foundation intends to support more than 40 new tools across those areas during the five-year pledge. Special scientific targets include the vaginal microbiome, which is the community of microbes in the vagina. They also include new kinds of treatments for preeclampsia, and birth control that does not use hormones. Basic biology questions in those fields are still unanswered.

Dr. Anita Zaidi, president of the Gates Foundation’s Gender Equality Division, said in the foundation’s press release, “For too long, women have suffered from health conditions that are misunderstood, misdiagnosed, or ignored.” She added, “We want this investment to spark a new era of women-centered innovation – one where women’s lives, bodies, and voices are prioritized in health R&D.”

Zaidi described the commitment as “the largest investment we’ve ever made in women’s health research and development, but it still falls far short of what is needed in a neglected and underfunded area of huge human need and opportunity.” Bill Gates said in a statement, “Women’s health continues to be ignored, underfunded, and sidelined.” He added, “Too many women still die from preventable causes or live in poor health. That must change. But we can’t do it alone.”

Read More: Does Endometriosis Raise Your Risk of Cancer? Here’s What the Research Shows

Why has women’s health research lagged behind?

The 1% figure from the 2021 McKinsey analysis covers a wide range of conditions. Preeclampsia is a dangerous rise in blood pressure during pregnancy. It has no approved therapy that treats the cause itself. In the United States, it affects 5% to 8% of all pregnancies. The World Health Organization has estimated that preeclampsia accounts for 16% of maternal deaths worldwide each year. The lack of a truly new treatment is a gap in basic scientific understanding, not only a gap in drug options.

Gestational diabetes is high blood sugar that develops during pregnancy. It is another large problem with few good solutions. A 2024 study in BMC Pregnancy and Childbirth found that it affects about 15% of pregnancies worldwide. The rate is rising. It remains one of the under-studied conditions the Gates Foundation pledge is meant to address.

Endometriosis is a condition in which tissue like the uterine lining grows outside the uterus. A peer-reviewed journal estimates that it affects 10% to 15% of women of reproductive age worldwide. Even so, many women wait years for a correct diagnosis. Patient surveys compiled by Allara Health show that over 65% of people with the condition were first given the wrong diagnosis.

Heavy menstrual bleeding follows a similar pattern. A 2022 study in BMC Women’s Health estimates that it affects 18% to 32% of women. The same study says it is often not reported. A 2026 analysis in The Lancet found that heavy menstrual bleeding “remains persistently overlooked and marginalised in clinical practice, policy agendas.” The condition is very common. That level of neglect is hard to explain on scientific grounds alone.

What economic case did the foundation make?

The announcement did not rely only on a moral argument. It also made a money case. The foundation pointed to analyses that say spending on women’s health pays off in economic output. It cited research that every $1 spent on women’s health yields $3 in economic growth. That $3 figure comes from those analyses. It is not a finding from a study the foundation itself ran. The foundation says closing the gender health gap could cut the world’s burden of lost working years.

The foundation is urging governments, philanthropists, investors, and the private sector to co-invest in women’s health innovations. It also wants partners to help shape new products. It wants to make sure treatments reach the women and girls who need them most. Zaidi has said the $2.5 billion was a “drop in the bucket” compared with what is needed. She called on the private sector, philanthropists, and governments to step in. The pledge is meant to spark wider investment, not to be a full solution on its own.

The unmet need is sharpest in lower-income regions. UNFPA’s Trends in Maternal Mortality report looked at 2023 data. It found that Sub-Saharan Africa accounted for 70% of maternal deaths worldwide. A 2025 WHO statement said maternal deaths fell by 40% worldwide between 2000 and 2023. That progress is fragile. Cuts in aid and pullbacks in health systems now threaten to undo gains that took a generation to achieve.

The foundation’s release listed three reasons for the five priority areas. One was evidence about where new tools can help the most. Another was direct input from women in low- and middle-income countries. The third was the high rate of wrong diagnoses. Gaps in medical training and knowledge drive many of those errors.

Which conditions is the funding meant to target?

Each of the five investment areas covers a group of conditions. In those conditions, science still lags behind the harm they cause. Pregnancy care and vaccines for mothers focus on pregnancy and delivery. That is when the risk of death remains highest for women in low-resource settings. Maternal health and nutrition looks at gaps in diet and at complications for both mother and newborn. Gynecological and menstrual health covers endometriosis and heavy menstrual bleeding. It also covers the vaginal microbiome, a community of microbes that is still poorly studied.

The birth control work aims to give women more options. That includes methods that do not use hormones and are not yet widely available. The infection category focuses on diseases passed through sex, including HIV. Those diseases place a heavier burden on women.

The HPV vaccine shows what sustained investment can produce. A 2025 Gavi report looked at cervical cancer vaccines in lower-income countries. It found that more than 1 million cervical cancer deaths have been prevented. An estimated 86 million girls are now protected. That outcome took decades of research and development. Most of the conditions now in the Gates Foundation’s portfolio are at the beginning of that same curve. Many still lack even a basic diagnostic tool that works in low-resource settings, let alone a treatment.

These conditions also connect to broader health. Doctors are talking more about PCOS. It is a hormone condition that can affect periods, fertility, and metabolism. A consensus paper in The Lancet recently proposed a new name, PMOS. The longer name is polyendocrine metabolic ovarian syndrome. Funding gaps have slowed understanding of a condition that affects one in eight women worldwide.

What does this mean for you?

The Gates Foundation’s $2.5 billion commitment is not a treatment. It is not a new drug. It is not a change to any government health benefit program. It is a research and development investment. It is meant to fund the science that could, in time, produce those things. The usual timeline between a funded research program and a treatment reaching a patient is years to decades.

The investment also marks an admission that today’s split of health research funding is a problem. The 2021 McKinsey analysis found that just 1% reaches conditions that affect only women, once cancer is set aside. For women living with endometriosis, heavy menstrual bleeding, or preeclampsia, research funding is what creates treatment options.

If your doctor has told you that heavy menstrual bleeding is “normal,” those answers are partly a result of how little research has been done. The same is true if you have been told that endometriosis symptoms are hard to explain. One concrete step is to ask your gynecologist what tests or clinical trials exist for your condition. The evidence is still limited. But it is growing. Specialists at academic medical centers are enrolling more patients in studies on these long-neglected conditions. Talk with your doctor about what is right for you. This is not a reason to start, stop, or change any treatment on your own.

Disclaimer: The author is not a licensed medical professional. The information provided is for general informational and educational purposes only and is based on research from publicly available, reputable sources. It is not intended to constitute, and should not be relied upon as, medical advice, diagnosis, or treatment. Always consult a licensed physician or other qualified healthcare provider regarding any medical condition, symptoms, or medications. Do not disregard, avoid, or delay seeking professional medical advice or treatment because of information contained herein.

AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.